← Back to headlines
Praxis Stock Surges 320% Following Biotech Investor's Substantial Buy
Praxis Precision Medicines' stock experienced a dramatic 320% surge after a single biotech investor increased their stake to nearly $600 million.
22 Feb, 19:36 — 22 Feb, 19:36
ℹOnly 1 source covers this story
